HomeDevelopment of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential March 28, 2012 print this article Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential Minea et al.; Toxicon. 2012 Mar 15;59(4):472-86
